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Background: Risk for obesity differs with ethnicity/race and is associated with insulin sensitivity (SI), insulin
responsiveness, and dietary glycemic load (GL). The objective of this study was to test the hypotheses that, 1)
obesity-prone, normal weight, African-American (AA) women would be more insulin sensitive than BMI-matched, never
overweight AA women; 2) increased adiposity over time would be associated with greater baseline SI and higher
dietary GL in AA but not European-American (EA) women; and 3) increased adiposity over time would be predicted by
SI in women with high but not low acute insulin response to glucose (AIRg).
Methods: Two controlled weight loss interventions were conducted involving overweight (BMI 25.0-29.9 kg/m2)
premenopausal AA and EA women. The first included matching with normal-weight (BMI <25.0 kg/m2) controls
following weight loss, and then comparing SI. The second included a 1-year follow-up of weight-reduced participants
to identify predictors of change in %body fat. Main outcome measure in the first study was insulin sensitivity (SI) as
assessed with intravenous glucose tolerance test (IVGTT), and in the second study was change in %fat, as assessed with
DXA, over one year. AIRg was assessed during IVGTT, and free-living diet was determined by food record.
Results: In the first study, formerly overweight AA women were 43% more insulin sensitive than BMI-matched never
overweight AA (P < 0.05). In the second study, SI was positively associated with change in %fat over 1 year only in AA
women (P < 0.05) and women with high AIRg (P < 0.05). In addition, AA who were insulin sensitive and who consumed
a higher GL diet tended to gain greater %fat (P = 0.086 for diet x SI interaction). In both studies, AA women had higher
AIRg (P < 0.001) than EA women.
Conclusions: Formerly overweight (obesity-prone) AA women were more insulin sensitive than never overweight AA
women, a quality that may predispose to adiposity, particularly when combined with a high GL diet. This ethnicity/
race-specific effect may be due to high insulin responsiveness among AA.
Keywords: Glycemic index, Diet, Insulin secretion, Acute insulin responseBackground
Risk for obesity is disproportionately high among African-
American (AA) women. U.S. epidemiological data indicate
that the age-adjusted rate of overweight and obesity is 82%
in AA women, and the prevalence of grade 3 obesity is
higher in AA women (18%) than in all other race/gender
sub-groups [1]. The reason for this disparity is not clear,* Correspondence: bgower@uab.edu
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reproduction in any medium, provided the orbut may relate to inherent differences in metabolic factors,
in particular, insulin responsiveness. Numerous studies
have shown that healthy AA relative to EA have up to
2-fold greater insulin response [2-6]. This higher insulin
response has been attributed to greater insulin secretion
and/or lower clearance, and is independent of differences
in insulin sensitivity [2-4,7].
There are several ways through which insulin may pro-
mote adiposity. Insulin has profound effects on both carbo-
hydrate and lipid metabolism [8]. Its actions on glucose
uptake promote glycogen synthesis and glucose oxidation.
Its lipogenic and anti-lipolytic effects promote triglycerideLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Schematic of experimental design for the two weight
loss intervention studies. For Study 1, overweight women were
provided with a controlled weight loss intervention (low-energy
diet) until they achieved BMI <25 kg/m2, at which time insulin
sensitivity was assessed and compared to a group of never
overweight women of BMI < 25 kg/m2. For Study 2, overweight
women were provided with a controlled weight loss intervention
(diet +/− exercise) until they achieved BMI <25 kg/m2, at which time
insulin sensitivity was assessed (“baseline”). Women were evaluated
for change in body composition after 1 year.
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adipose tissue accrual via these processes. In addition, in-
sulin may affect hunger/satiety and thereby food intake
via central or peripheral actions [9,10]. However, the effect
of insulin on voluntary food intake in humans is complex,
and neither its actions nor their mechanisms have been
entirely elucidated [11].
Because insulin secretion is stimulated by glucose inges-
tion, dietary carbohydrate (CHO) quantity and/or quality
may interact with insulin secretion to influence adiposity.
In support of this possibility, interactive effects of insulin
secretion with diet on weight gain have been documented
in both humans and animal models. Within a large popu-
lation of healthy free-living women and men, 6-year
weight gain was positively associated with insulin concen-
trations at 30 and 60 min following ingestion of oral glu-
cose [12]. The relationships were significant only among
individuals consuming a higher CHO, lower fat, diet. In
rats, an interaction between diet and indices of glucose
metabolism regarding weight gain has been reported [13].
Analogous data have been reported with weight loss,
where greater weight loss occurred in conjunction with a
low glycemic load (GL) diet within individuals with a high
insulin response at baseline [14].
Further, the effects of insulin on physiological processes
may be enhanced by greater sensitivity to insulin. Several
reports have indicated that insulin sensitivity predicts
weight gain. Individuals who were more insulin sensitive
at baseline gained more weight or %fat [15-17] over a
given follow-up period. Given their relative hyperinsuline-
mia, AA may be particularly sensitive to the effects of both
diet and insulin sensitivity on risk for obesity.
The objective of the study was to test the hypotheses
that, 1) obesity-prone, normal weight, African-American
(AA) women would be more insulin sensitive than BMI-
matched, never overweight AA women; 2) increased adi-
posity over time would be associated with greater baseline
SI and higher dietary GL in AA but not European-
American (EA) women; and 3) increased adiposity over
time would be predicted by SI in women with high but not
low acute insulin response to glucose (AIRg). To address
these hypotheses, we examined data from two controlled
diet intervention studies involving overweight women.
The first involved matching weight-reduced women with
normal-weight (BMI <25.0 kg/m2) controls to determine if
obesity propensity affected insulin sensitivity. The second
involved a 1-year follow-up of weight-reduced participants
to determine if insulin response, insulin sensitivity, and
dietary GL predicted weight gain.
Methods
Study 1: Participants and study design
The data used for this study were from an intervention
project designed to determine if overweight/obese womenare physiologically different from never-overweight, lean
control women. Details and main outcomes of the study
have been published [18-20]. In brief, we have reported
that weight loss has favorable effects on metabolic risk fac-
tors in this cohort of women [18]; that energy expenditure
does not differ in weight-reduced women and lean con-
trols [20]; and that gain in adiposity in the combined co-
hort was related to respiratory quotient [19]. In none of
these previous reports did we determine whether insulin
sensitivity differed in weight-reduced women vs lean con-
trols, and whether ethnicity/race affected this comparison;
this is the objective of the current study.
Participants were 82 healthy, sedentary (≤1 day/week
structured exercise), pre-menopausal women with (n = 35)
or without (n = 47) a personal and family history of
obesity. Overweight women were recruited at a BMI of
25–29.9 kg/m2, and underwent diet-induced weight loss
as described [18]. These women were evaluated after redu-
cing their BMI to <25 kg/m2, immediately following a
4-week period of supervised weight stability (Figure 1).
The weight loss program involved consuming a low-
energy diet (800 kcal/d) until target BMI was reached
(approximately 16 weeks). Fifty women started the weight
loss program. Of the 50 women who started the weight
loss program, 35 both completed the program and had a
successful post-weight-loss insulin sensitivity test (i.e., a
test not compromised by failed iv or hemolyzed blood
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same time as the weight loss intervention, a never over-
weight “control” group (n = 50) was recruited that had a
similar ethnic composition (50% EA and 50% AA) and age
as the starting group of obesity-prone women, and whose
BMI was within the target range of the obesity-prone
group (20–25 kg/m2). The never overweight group had no
personal or family history of obesity. No participant used
medications that affect body composition or metabolism.
All were nonsmokers and reported experiencing menses
at regular intervals. Prior to testing, all participants were
placed on a weight-maintenance diet for 4 weeks. At the
end of the 4-week weight-maintenance period, body com-
position, fat distribution, and metabolic outcomes were
assessed under controlled conditions during an in-patient
stay at the General Clinical Research Center (GCRC). All
testing was conducted within 12 days of menses.
Study 2: Participants and study design
The data used for this study were from an intervention
project designed to determine if aerobic or resistance
training was more effective in maintaining weight loss in
a group of overweight/obese AA and EA women. Details
and main outcomes of the study have been published
[21-23]. We also reported that in the combined group of
women, greater insulin sensitivity predicted greater gain
in %body fat over 1 year; that greater glucose disposal
predicted less gain in intra-abdominal fat; and that diet-
ary glycemic load interacted with insulin sensitivity to
predict gain in adiposity [17]. In this earlier study, the
data were not examined separately by ethnicity/race.
Thus, the objective of this study was to determine if
ethnicity/race differences existed in the association of in-
sulin sensitivity with changes in adiposity, and if these
associations were mediated by postchallenge insulin
response.
Participants were 103 healthy overweight (BMI 25–
29.9 kg/m2) pre-menopausal women with a family history
of overweight in at least one first-degree relative. Women
underwent a controlled period of weight loss by diet alone
or diet in combination with exercise as previously
described [24,25]. None used medications that affect body
composition or metabolism. All were nonsmokers and
reported experiencing menses at regular intervals. For the
purposes of this study, “baseline” was taken as post weight
loss, at which time all participants had a BMI of <25 kg/m2
(Figure 1). Insulin sensitivity data were not available on
several participants due to failed iv or hemolyzed blood
samples. Thus, data were used from only those participants
having insulin sensitivity information.
Prior to baseline testing, all participants were placed
on a weight-maintenance diet for 4 weeks. At the end of
the 4-week weight-maintenance period, body compos-
ition and metabolic outcomes were assessed undercontrolled conditions during an in-patient stay at the
GCRC. All testing was conducted within 12 days of
menses. Women then entered a 1-year follow-up period
where they were encouraged to maintain their reduced
weight status and were offered nutrition education
classes. Those women who were assigned to the exercise
arms of the weight loss intervention also had access to a
gym facility during the follow up period, and were encour-
aged to continue to exercise. Preliminary analyses indicated
that results from women prescribed nutrition education
plus exercise did not differ from those of women pre-
scribed nutrition education without exercise. Thus, a
“group” variable was not included in the final analyses. At
the conclusion of the 1-year follow-up period, body com-
position was assessed.
Studies were approved by the Institutional Review
Board for Human Use at the University of Alabama at
Birmingham (UAB). All women provided informed con-
sent before participating.
Body composition
Body composition was measured by dual-energy X-ray
absorptiometry (DXA) in the Department of Nutrition
Sciences at UAB. A Lunar DPX-L (software version 1.35,
November 1997; GE-Lunar, Madison, WI) was used in
the first study, whereas a Lunar Prodigy densitometer
and enCORE software version 6.10.029 (2002) was used
in the second study. Participants were scanned in light
clothing while lying flat on their backs with arms at
their sides.
Insulin sensitivity
Insulin sensitivity was assessed on an in-patient basis in
the GCRC after an overnight fast with a tolbutamide-
modified (first study) or an insulin-modified (second
study) frequently-sampled intravenous glucose tolerance
test (IVGTT). Prior to testing, flexible intravenous cathe-
ters were placed in the antecubital spaces of both arms.
Three, 2.0 ml blood samples were taken over a 20-min
period for determination of basal glucose and insulin (the
average of the values was used for basal "fasting" concen-
trations). At time "0", glucose (50% dextrose; 11.4 g/m2)
was administered intravenously. Tolbutamide (125 mg/m2)
or insulin (0.02 U/kg, Humulin, Eli Lilly and Co.,
Indianapolis) was injected at 20 min post glucose injec-
tion. Blood samples (2.0 ml) were collected at the
following times (min) relative to glucose administration:
2, 3, 4, 5, 6, 8, 10, 12, 15, 19, 20, 21, 22, 24, 26, 28, 30,
35, 40, 45, 50, 55, 60, 70, 80, 100, 120, 140, 180.
Sera were stored at −85°C until analyzed. Glucose and
insulin values were entered into the MINMOD com-
puter program (ver. 3, © Richard N. Bergman) for deter-
mination of the insulin sensitivity index (SI) [26]. The
acute insulin response to glucose (AIRg) was calculated
Table 1 Objective 1: characteristics of the study population (mean ± SEM) by obesity status [formerly overweight
(obesity-prone) or never overweight] and ethnicity/race
Formerly overweight Never overweight
EA AA EA AA Main effects*
Age (yr) 38.4 ± 1.3 36.4 ± 1.2 31.4 ± 1.1 31.8 ± 1.1 Obesity
Body weight (kg) 66.3 ± 1.4 64.4 ± 1.3 62.8 ± 1.1 60.3 ± 1.2 Obesity
BMI (kg/m2) 24.3 ± 0.3 23.9 ± 0.3 23.0 ± 0.2 22.6 ± 0.2 Obesity
Body fat (%) 34.0 ± 1.1 33.6 ± 1.1 32.5 ± 1.0 31.6 ± 1.0
Fasting Insulin (μIU/ml) 7.5 ± 0.7 7.3 ± 0.7 7.4 ± 0.6 7.0 ± 0.6
SI [x10
-4 min-1/(μIU/ml)] 5.94 ± 0.86 5.48 ± 0.77 7.91 ± 0.95 4.09 ± 0.53 Race, Ob x Race
AIRg (μIU/ml x 10 min) 357 ± 67 506 ± 92 305 ± 47 536 ± 87 Race
*Significant (P < 0.05) main effects of obesity status (Obesity), ethnicity/race (Race), or the Obesity by race/ethnicity (Ob x R) interaction by ANOVA;
unadjusted data.
Abbreviations: EA = European-American; AA = African-American; BMI = body mass index; SI = insulin sensitivity index; AIRg = acute insulin response to glucose.
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minutes 0–10 following glucose injection using the trap-
ezoidal method.
Diet
For the second study, information on habitual diet was
collected using 4-d food records. Participants were asked
to complete the records at the 1-year time point, prior to
the 2 weeks of food provision and metabolic evaluation.
Instructions regarding completion of the record were
provided in person by a registered dietitian. A handout
that reiterated the instructions and contained information
regarding portion size also was provided. Participants were
directed to provide brands of food items, location of meal
consumption (e.g., cafeteria, restaurant, home), and method
of cooking (e.g., fried, broiled), and to specify the type of fatFigure 2 Insulin sensitivity by ethnic group and obesity status.
Formerly overweight (obesity-prone) AA women were more insulin
sensitive than never overweight AA women (*P < 0.05), whereas
obesity-prone EA women did not differ from never overweight EA
women (P = 0.158; adjusted for %fat). P < 0.05 for the group x
ethnicity/race interaction.used in cooking. A dietitian reviewed each record upon
completion, and contacted participants to clarify any ques-
tions. Food records were analyzed by a registered dietitian
using the Nutrition Data System for Research (NDS-R)
software (Nutrition Coordinating Center, University of
Minnesota, MN, version 2007). Only food records with at
least 3 of the 4 days completed were used for analysis, and
the days were averaged for mean nutrient intake. Because
not all women returned the records, dietary information
was available on 68 women. Mean daily dietary glycemic
load, a measure that reflects both carbohydrate quantity
and quality [27], was used as an independent variable in
statistical analysis.
Laboratory analyses
All analyses were conducted in the Core Laboratory of
UAB’s GCRC, Diabetes Research and Training Center
(DRTC), and Nutrition Obesity Research Center (NORC).
Glucose was measured using an Ektachem DT II System
(Johnson and Johnson Clinical Diagnostics, Rochester,
NY). In the Core laboratory, this analysis has a mean
intra-assay CV of 0.61%, and a mean inter-assay CV of
2.56%. Insulin was assayed in duplicate using Diagnostic
Products Corporation (Los Angeles, CA) "Coat-A-Count"
kits (first study) or Linco Research Inc. double-antibody
RIA (St. Charles, MO, second study). In the Core Labora-
tory, these assays have a sensitivity of 1.9 μIU/ml, a mean
intra-assay CV of 5%, and a mean inter-assay CV of 6%
(DPC), and a sensitivity of 3.35 μIU/ml, a mean intra-
assay CV of 3.49%, and a mean inter-assay CV of 5.57%
(Linco).
Statistical analysis
All statistical analyses were performed using SAS (version
9.2; SAS Institute, Inc., Cary, NC). Fasting insulin, AIRg,
and SI were log10 transformed prior to statistical analysis.
All statistical tests were two-sided and were performed
using a Type I error rate of 0.05.
Table 2 Objective 2: characteristics of study population (mean ± SEM) by ethnic/race group at baseline (A) and at
1 year (B)
A. Baseline EA (n = 46) AA (n = 57)
Age (yr) 34.7 ± 0.9 34.5 ± 0.8
Body weight (kg) 65.8 ± 0.9 64.9 ± 0.8
Body mass index (kg/m2) 23.7 ± 0.2 23.9 ± 0.1
Body fat (%) 34.1 ± 0.7 32.3 ± 0.6*
Fasting glucose (mg/dL) 87 ± 1 83 ± 1**
Fasting insulin (μIU/ml) 8 ± 3 8 ± 3
Insulin sensitivity [SI; x 10
-4 min-1/(μIU/ml)] 4.73 ± 0.28 3.76 ± 0.25**
Acute insulin response to glucose (AIRg; μIU/ml x 10 min) 416 ± 65 794 ± 59***
B. 1 year. EA AA
Energy intake (kcal/d)1 1399 ± 52 1281 ± 49
Carbohydrate intake (g/d) 1 177 ± 9 157 ± 9
Protein intake (g/d) 1 63 ± 3 54 ± 3*
Fat intake (g/d) 1 51 ± 3 50 ± 3
Glycemic load1 99 ± 5 91 ± 5
Δ%fat +4.8 ± 0.4 +5.7 ± 0.4
Δ Lean mass (kg) −0.09 ± 0.23 −0.30 ± 0.20
*P < 0.05, **P < 0.01, ***P < 0.001 for EA vs AA.
1For diet data: n = 31 EA; n = 36 AA.
Abbreviations: EA = European-American; AA = African-American.
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[formerly overweight (obesity-prone) vs never over-
weight], ethnicity/race, and the obesity status x ethni-
city/race interaction on participant characteristics and
main outcome variables including SI, were determined
by ANOVA using unadjusted data. 2-way ANCOVA
(adjusting for %fat) was subsequently used to further
examine the main effects of ethnicity/race and obesity
status, and the obesity status x ethnicity/race interaction,
on SI.
For the second study, between-group differences in
participant characteristics at baseline and 1 year were
determined using ANOVA. Pearson correlation analysis
was used to examine the associations of dietary GL with
fasting insulin and AIRg within each ethnic/race group.
To examine independent and interactive effects of insu-
lin phenotype and dietary GL with change in %fat, parti-
cipants were divided into groups based on median
categories of SI and GL (high/low for each variable).
Two-way ANOVA was conducted within each ethnic/
race group for the dependent variable change in %fat,
examining main effects of GL, SI, and the GL x SI inter-
action. Because all significant observations occurred
within the AA women, additional analyses were con-
ducted to determine if greater AIRg in AA could poten-
tially explain the unique association of SI with change in
% fat in this group. These analyses were conducted by
ANCOVA (adjusting for GL) within AA and EA separ-
ately, and within participants with high and low AIRg
separately (based on median AIRg).Results
Participant characteristics for the first study are shown in
Table 1 by obesity status [formerly overweight (obesity-
prone), never overweight] and ethnicity/race. Formerly
overweight women on average were older, weighed more,
and had a higher BMI. EA women had higher SI.
Analysis of covariance for SI by obesity status [formerly
overweight (obesity-prone), never overweight] and ethni-
city/race revealed a significant main effect of ethnicity/race
(lower among AA; P < 0.01), and a significant obesity
status x ethnicity/race interaction (P < 0.05, data adjusted
for %fat). Formerly overweight (obesity-prone) AA women
were 43% more insulin sensitive than never overweight
AA women (P < 0.05). In contrast, formerly overweight
(obesity-prone) EA women were 22% less insulin sensitive
than never overweight EA women (Figure 2).
Participant characteristics for the second study are
shown in Table 2A by ethnic/race group. At baseline, all
women were BMI <25 kg/m2 (weight reduced, formerly
overweight). Ethnic/race composition of the participants
was 44% European-American and 56% African-American.
AA had lower SI, lower fasting glucose, and higher AIRg.
The 68 women with available dietary intake data did not
differ in any way from the group as a whole, being similar
with respect to age, BMI, ethnic/race distribution, and in-
sulin sensitivity [17].
Dietary information at 1 year, and changes in out-
comes of interest after 1 year, are shown in Table 2B. EA
women consumed more protein (g/d) than AA women.
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Figure 3 Change in %fat over 1 year by median glycemic load (GL) and median insulin sensitivity (SI) in AA women (A, B) and EA
women (C, D). Data shown are mean ± SEM from 2-way ANOVA (A, C), and as individual points (B, D); some points reflect data from more than
one individual. Histograms with different lower-case letters differ significantly (P < 0.05). The model for AA women indicated a significant main
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*
Figure 4 Change in %fat over 1 year within subgroups
stratified by median AIRg and median SI; data adjusted for GL.
Only within women with high AIRg was insulin sensitivity
significantly associated with change in %fat..
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averaged ~1300 kcal/d, suggesting that the women under-
reported their intake, as previously documented [28].
Pearson correlation analysis indicated that dietary GL was
associated with fasting serum insulin concentration among
AA (r = 0.48, P < 0.01) but not among EA (r = −0.04,
P = 0.853). GL was not associated with AIRg in either
group (AA: r = −0.17, P = 0.379; EA: r = −0.12, P = 0.535).
The ANOVA model for AA women indicated a signifi-
cant main effect of SI (P < 0.05), as well as an SI x GL
interaction of P = 0.086 (Figure 3A). Within AA women,
those who were relatively insulin sensitive and who con-
sumed a relatively high GL diet gained or tended to gain
greater %fat than other subgroups (P < 0.05 vs both Low
SI groups, and P = 0.068 vs High SI, Low GL). Neither
SI nor GL were significant for EA women (Figure 3B).
When data were stratified by high vs low AIRg, SI was a
significant predictor of change in %fat only in women
with high AIRg (Figure 4).
Discussion
The major conclusion of this study is that within AA
but not EA women, obesity predisposition appears
related to insulin sensitivity, and that this predisposition
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sion is based in part on the observation that lean, formerly
overweight (obesity-prone) AA but not EA women were
significantly more insulin-sensitive than their never-obese
counterparts. We also found that changes in adiposity
over 1 year were related to insulin sensitivity in AA but
not EA women, and in women with high but not low insu-
lin response.
Although we cannot determine from this study why
obesity predisposition was associated with insulin sensi-
tivity in AA and not EA, this ethnic/race difference likely
relates to greater insulin responsiveness in AA. The pro-
vocative work of Ludwig and colleagues has shown that
serum insulin concentration at 30 minutes after an oral
glucose load is a significant predictor of weight gain or
loss in certain individuals [12,14]. Numerous studies
have shown that healthy AA relative to EA have up to a
2-fold greater insulin response [2-6]. Similarly in this
study, AA women had significantly greater AIRg than
EA women. Thus, we speculated that the higher AIRg
within the AA women may have explained the race-
specific results concerning the association of SI with
change in adiposity. This hypothesis was supported by
the observation that, when analyses were stratified by
median AIRg (high/low), an association of SI with
change in %fat was observed only within those women
with high AIRg. The physiological basis for greater insu-
lin responsiveness in AA women is not clear. Possible
explanations include estradiol, which is greater in AA vs
EA [29], is associated with AIRg, and promotes beta-cell
survival [30]. Alternatively, reactive oxygen species,
which are reported to be higher in AA [31] and which
play an integral role in insulin secretion [32] may con-
tribute to greater AIRg in AA. Further research is war-
ranted to understand the basis for greater insulin
responsiveness in AA.
In previous studies, the association of insulin response
with weight gain or loss was observed only within indivi-
duals who consumed a relatively high GL diet [12,14].
Thus, we also examined whether dietary GL was asso-
ciated with change in %fat over 1 year within AA and
EA, groups that differ dramatically in their insulin re-
sponsiveness. Results indicated that AA women appeared
uniquely sensitive to diet quality regarding change in adi-
posity, an effect that was modulated by SI. Only within
those AA women who were relatively insulin sensitive did
dietary GL appear to influence change in %body fat. Al-
though this observation only approached significance
(P = 0.086), it supports the hypothesis that higher dietary
GL and greater insulin sensitivity synergize to promote
adiposity in AA women, who are uniquely sensitive to
these factors due to their greater insulin responsiveness.
Confirmation of this observation may be important, as it
has implications for development of dietary strategies tominimize weight gain or promote weight loss in AA
women.
In the broader context of metabolic health, low insulin
sensitivity, or insulin resistance, is considered to be an
unfavorable condition due to its association with disease
risk [33]. Paradoxically, our data and others’ [15,16] sug-
gest that in some cases insulin resistance may protect
against obesity. These discrepant observations may
imply that the association between insulin resistance and
metabolic disease is confounded by weight gain, ectopic
fat accumulation, inactivity, and poor diet, factors that
may lead to both insulin resistance and disease. In other
words, insulin resistance in the context of chronic meta-
bolic disease may, to some extent, be a marker for positive
energy imbalance and disease risk-promoting lifestyle.
However it is also possible that low SI is a double-edged
sword, conferring both leanness and risk for chronic meta-
bolic disease. We cannot determine from this study
whether the “protective” aspect of low SI regarding adipos-
ity is beneficial to AA women regarding long-term health.
Obesity is not as tightly associated with morbidity and
mortality in AA as in EA [34,35]. In contrast, AA are dis-
proportionately burdened by type 2 diabetes [36], a disease
that results in part from insulin resistance [37]. Further
study is needed to determine if lower insulin sensitivity in
AA women is associated with greater risk for type 2 dia-
betes, even in the absence of obesity.
Strengths of this study were the longitudinal study design,
the use of the weight-reduced model, and characterization
of insulin sensitivity using IVGTT. Limitations were the
convenience sample of volunteers, which may not have
been representative of, or generalizable to, the larger popu-
lation, and the use of self-reported diet; however, reporting
bias was similar in AA and EA women [28].
Conclusions
Lean, formerly overweight (obesity-prone) AA women
were more insulin sensitive than their never overweight
counterparts. Further, greater SI predicted an increase in
%fat over 1 year only in women who were AA or had
high AIRg. Dietary GL tended to interact with SI to pre-
dict %fat gain in AA. Taken together, these findings sug-
gest that insulin sensitivity, insulin responsiveness, and
dietary GL interact to affect adiposity. Insulin sensitive
AA women may be uniquely prone to adiposity due to
their greater insulin responsiveness. Whether dietary
strategies can be indentified to prevent or reverse obesity
in AA warrants future study.
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